The carboxyl-terminal two-thirds of the ADP/ATP carrier polypeptide contains sufficient information to direct translocation into mitochondria by Pfanner, Nikolaus et al.
Communication Vol. 262, No. 31, Issue of November 5, pp. 14851-14854,1987 0 1987 by The American Society for Biochemistry and Molecular Biology, Inc. 
Printed in U.S.A.  
THE J O U R N A L  OF BIOLOGICAL CHEMISTRY 
The Carboxyl-terminal Two- 
thirds of the ADP/ATP  Carrier 
Polypeptide Contains Sufficient 
Information to Direct 
Translocation into Mitochondria* 
(Received for publication, July 10,  1987) 
Nikolaus Pfanner, Peter Hoeben, 
Maximilian Tropschug, and Walter Neupert 
From the Znstitut  fur  Physiologische  Chemie,  Universitat 
Munchen, 8000 Munchen 2, Federal  Republic of Germany 
The precursor of the mitochondrial inner membrane 
protein ADP/ATP carrier is cytoplasmically synthe- 
sized without an amino-terminal peptide extension. We 
constructed a truncated precursor lacking the 103 
amino acids from the amino terminus (about a third of 
the protein). Import of the truncated precursor into 
mitochondria showed the import characteristics of the 
authentic precursor, including nucleoside triphosphate 
dependence, requirement for a protease-sensitive com- 
ponent  on the mitochondrial surface, two-step specific 
binding to the outer membrane,  and  membrane poten- 
tial-dependent translocation into the inner membrane. 
We conclude that, in contrast to all other mitochondrial 
precursor proteins studied so far, domains of the ADP/ 
ATP carrier distant from the amino terminus can carry 
specific targeting information for transport into mito- 
chondria. 
The  transport of proteins  into  mitochondria involves  sev- 
eral  distinct steps: synthesis of precursors  on cytosolic  poly- 
somes, nucleoside triphosphate (NTP)-dependent unfolding 
of precursors,  binding of precursors  to receptor sites  on  the 
mitochondrial surface, insertion into the outer membrane, 
translocation via contact  sites between outer  and  inner  mem- 
branes,  requirement for  a membrane  potential (A#) for inser- 
tion into the inner membrane, and proteolytic removal of 
amino-terminal  peptide  extensions  (presequences) (1, 2). 
There is abundant evidence that presequences contain  suf- 
ficient  information for targeting of proteins  to  mitochondria 
(reviewed in Ref. 3). Precursors from  which the  presequences 
have been  removed are usually not imported (3, 4). The 
question  arises, where is  the  targeting  information  contained 
in  precursors which are  synthesized  without cleavable prese- 
quences?  Studies  with  the  70-kDa  protein of the  yeast  outer 
mitochondrial membrane (5) and the ADP/ATP carrier of 
the  yeast  inner  mitochondrial  membrane (6) suggest that  the 
targeting  information  is  contained in the  amino-terminal  part 
of the  protein.  Mutations  in  the  extreme  amino  terminus of 
F,-ATPase  subunit (3 allowed import of subunit (3 without a 
presequence (4). Thus,  it was generally assumed  that  amino- 
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terminal  protein sequences carry  the  mitochondrial  targeting 
signals. 
In  order  to  study  whether  the  amino-terminal  part of the 
Neurospora  crassa precursor  to  the  ADP/ATP  carrier is es- 
sential for targeting, we constructed a precursor  lacking the 
amino-terminal 103 amino acid residues. Surprisingly, this 
truncated precursor (C104-313)1 was imported into mitochon- 
dria.  Its  import showed the  import  properties of the  authentic 
ADP/ATP  carrier including a requirement for NTPs, for a 
protease-sensitive  component  on  the  mitochondrial  surface, 
and for A+ (7-12). The  binding  to  the  outer  membrane could 
also  be resolved into two distinct  steps (11, 12).  We conclude 
from these  observations  that  the  carboxyl-terminal  two-thirds 
of the  ADP/ATP  carrier  contain specific mitochondrial  tar- 
geting information. 
EXPERIMENTAL PROCEDURES 
D N A  Manipulations and Construction of C104-313-A full-length 
cDNA coding for the ADP/ATP carrier (13) was isolated from a N .  
crussa library (14). Cloning, shortening of the 5’  end of the cDNA 
with Ba131 (Biolabs), ligation into pGEM 4  (Promega), and transfor- 
mation  into Escherichia coli strain DH1 were carried out essentially 
as described (15, 16). One clone (KPH6) gave rise to a translation 
product of 22 kDa (recognized by an antiserum prepared against 
isolated ADP/ATP carrier) when the truncated cDNA was tran- 
scribed with SP6 RNA polymerase and  the capped transcripts were 
translated in a reticulocyte lysate. DNA sequencing (17) of both 
strands with an SP6 primer and a primer (5’GGCGGACTTGGC- 
GTCGTTGG3’) corresponding to nucleotide positions 459-440  of the 
antisense strand of ADP/ATP carrier cDNA revealed that  the cDNA 
had been truncated as result of the Ba131 treatment  to nucleotide 
position 227 (13). The predicted molecular weight of a protein starting 
at the  next available ATG (nucleotide position 310) is 22,313. This 
correlates very  well with the observed apparent molecular mass of  22 
kDa. This implies that  the first 103 amino acid residues of the protein 
are deleted. 
Import of C’”-313 into  Neurospora  Mitochondria-Isolation of Neu- 
rospora mitochondria and binding and import of radiolabeled precur- 
sor were performed as described previously (9, 11, 12, 18). The 
reaction volume for binding and import was  200  pl including a buffer 
containing 3% (w/v) BSA (9). Each reaction contained 50  pg  of 
mitochondrial protein. 
RESULTS 
Import of C104-313 into  Mitochondria  Requires A+ and 
NTPs-A truncated  precursor (Mr 22,313) of the  ADP/ATP 
carrier  lacking  the  amino-terminal 103 amino acid residues 
was constructed as described under “Experimental Proce- 
dures.” Reticulocyte  lysate containing  the  truncated precursor 
dria  in  the presence of ascorbate  plus  TMPD which generates 
a membrane  potential via complex IV  of the  respiratory  chain 
(19). After incubation a t  25 “C for 25 min,  proteinase K was 
added at  a concentration of  250 pg/ml  (Fig. 1, Reaction 1). In 
Reactions 2 and 3 of Fig. 1, A# was dissipated by the K+ 
ionophore  valinomycin (in  the  presence of 80 mM K’ outside), 
the  inhibitor of complex I11 antimycin A, and  the  inhibitor of 
the  FoFI-ATPase oligomycin. In  the presence of A+, C104-313 
was imported  into a protease-protected location  (Fig. 1, Re- 
action l), whereas  in  the absence of A#, import was strongly 
’ The abbreviations used are: C104-313, carboxyl-terminal two-thirds 
of the ADP/ATP carrier; BSA,  bovine serum albumin; TMPD, 
N,N,N‘,N‘-tetramethylphenylenediamine. 
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1 2 3  
Asc/TMPD + - -  
VaIinomycin - + - 
Anti A/Oli - + +  
FIG. 1. Import  of C1m-s's requires  the  mitochondrial mem- 
brane potential. Reticulocyte lysate  containing 35S-labeled C1"313 
and isolated Neurospora mitochondria were incubated in the presence 
of ascorbate (Asc) plus TMPD (Reaction l), valinomycin (Reaction 
2), and antimycin A (Anti A) plus oligomycin (Oli) (Reactions 2 and 
3) for 25 min at  25 "C as described (11). Reactions were treated with 
proteinase K (250 pg/ml final concentration). The reisolated mito- 
chondria were analyzed by SDS-polyacrylamide gel electrophoresis. 
A fluorograph of the dried gel is shown. C, imported C1"313. 
1 2 3 4 5 6 7  
Apyrase - ++ + + + + + 
ATP(mM) - - - 4 8 "  
GTP(mM1 - - - - - 4 8  
FIG. 2. Import  of C1""ls requires NTPs. Reticulocyte lysate 
and isolated mitochondria were pretreated with apyrase (30 units/ml 
in reaction 2 (++); 7  units/ml in Reactions 3-7 (+)) or received an 
apyrase preparation that had been heated to 95 "C prior to use 
(corresponding to 30 units/ml; Reaction 1 (-)) as described (18). 
Reticulocyte lysate and mitochondria were mixed and incubated  in 
the presence of antimycin A, oligomycin, ascorbate, and TMPD. 
Reactions 4-7 received ATP  or  GTP  as indicated. Import and  further 
treatments were performed as described for Reaction 1 of Fig. 1. C, 
imported C'"313. 
inhibited (Fig. 1, Reactions 2  and 3). On  lysis of mitochondria 
with Triton X-100, C104-313 was  completely  digested  by pro- 
teinase K the precursor in reticulocyte lysate was similarly 
completely  digested by proteinase K (not shown). The import 
efficiency (i.e. ratio between imported precursor and total 
added precursor) after incubation for 25 min at  25 "C was up 
to 30% of the import efficiency of the  authentic ADP/ATP 
carrier (10). 
Reticulocyte lysate and mitochondria were depleted of ATP 
and ADP by preincubation with apyrase (an adenosine 5'- 
triphosphatase and an adenosine 5"diphosphatase). Reticu- 
locyte lysate and mitochondria were  mixed and incubated in 
the presence of oligomycin and ascorbate plus TMPD as 
described previously (12, 18). The control reaction that re- 
ceived an apyrase preparation boiled prior to use showed 
import of C1"313 into the protease-protected location (Fig. 2, 
Reaction 1). Pretreatment with apyrase inhibited the import 
(Fig. 2, Reactions 2 and 3). Readdition of ATP or GTP 
restored import (Fig. 2, Reactions 4-7). The import of C104-313 
therefore requires both A+ and  NTPs. 
Specific Binding of C104-313 to Mitochondria Occurs in Two 
Distinct Steps and Requires NTPs-C'"~~~ was bound to 
mitochondria at  25 "C in the absence of A$ (addition of 
antimycin A and oligomycin); the mitochondria were then 
reisolated and resuspended in BSA-containing buffer (9) in 
the presence of antimycin A and oligomycin. The reaction 
mixture was halved.  One  half  received ascorbate plus TMPD 
to generate a membrane potential. After incubation a t  25 "C, 
both halves were treated with proteinase K (250 pg/ml) to 
test for imported C104-313. The amount of C'"313 imported 
from the bound state (Fig. 3, Reaction Pa)  was comparable to 
the control reaction where ascorbate plus TMPD was present 
in the first 25 "C incubation (Fig.  3, Reaction la). Bound C'" 
313 appeared to be tightly associated with mitochondria since 
washing of mitochondria prior to import failed to remove the 
bound precursor (Fig.  3, Reactions 3a and 4a). 
The import pathway of authentic ADP/ATP carrier can be 
"" 
o b  o b   o b  o b  
1 2 3 4  
Pre-blndlng - 
Woshes - I .  2. 
Asc/lMPD 7777 
FIG. 3. C1"s can be imported  from the bound state. Retic- 
ulocyte lysate and isolated mitochondria were incubated  in the pres- 
ence of antimycin  A and oligomycin for 25 min at  25 "C; Reaction la 
(control) additionally contained  ascorbate (Asc) plus TMPD. Mito- 
chondria were reisolated and resuspended in BSA-containing buffer 
in  the presence of antimycin  A and oligomycin (mix A). Reactions 1 
and 2 were left on ice. Mitochondria of Reactions 3 and 4 were washed 
(once or twice, respectively) in mix A and finally resuspended in mix 
A. Reactions 2a, 3a, and 4a received ascorbate plus TMPD,  and all 
reactions were incubated for 15 min at  25 "C. After treatment with 
proteinase K (250 pg/ml final concentration), mitochondria were 
reisolated and  further  treated  as described in  the legend to Fig. 1. 
Imported C1M413 was quantified by densitometry. 
c -  
Pro1 K 
FIG. 4. Binding  of C1".s to mitochondria  requires NTPs. 
Reticulocyte lysate and mitochondria were incubated with a boiled 
apyrase preparation (corresponding to 80 units/ml (-)) or active 
apyrase (80 units/ml (++) or 5 units/ml (+)). Reticulocyte lysate and 
mitochondria were mixed and incubated in  the presence of antimycin 
A  (Anti A )  and oligomycin (Oli) for 25 min at  25 "C. Mitochondria 
were reisolated and resuspended in buffer containing BSA, antimycin 
A, oligomycin, and a boiled apyrase preparation (corresponding to 
0.25 units/ml (-)) or active apyrase (0.25 units/ml (++ and +)). 
Reactions were halved, and one half was treated with trypsin (20 pg/ 
ml final concentration). All reactions received ascorbate (Asc) plus 
TMPD  and 8 mM GTP  and were incubated for 15 min a t  25 "C. 
Reactions were again halved, and one half was treated with proteinase 
K (Prot K, 250 pg/ml final  concentration). Mitochondria were reiso- 
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A )  Binding 
c -- 
1 2 3  
Trypsin (pg /ml )  0 20  40 
9) Import 
1 2 3 4  
Trypsin (pg/ml) 0 40 20 40 
+ST1 
FIG. 5. Pretreatment of mitochondria with trypsin inhibits 
binding and  import of C10'-s13. Mitochondria of Reactions 2 and 
3 in panel A and Reactions 3 and 4 in panel B were pretreated with 
trypsin as described (11); Reaction 2 in panel B received trypsin  plus 
soybean trypsin  inhibitor (STT), and Reactions 1 in panels A and B 
received water. Mitochondria were incubated with reticulocyte lysate 
in the presence of valinomycin, antimycin A, and oligomycin (panel 
A )  or in the presence of ascorbate plus TMPD (panel B )  for 20 min 
at  25 "C. Reactions were treated with proteinase K (10 pg/ml for 
panel A; 250 pg/ml for panel B )  and  further  treated as described in 
the legend to Fig. 1. C, bound or imported 
resolved into several distinct  steps (11, 12). Binding of pre- 
cursor to the mitochondrial surface (generation of the stage 2 
intermediate) requires NTPs. Higher levels of NTPs are 
necessary  for insertion of the precursor into  the  outer mem- 
brane (stage 3 intermediate) where it is protected against 
treatment with trypsin or low concentrations of proteinase K 
which  digest the initial binding sites. Translocation of pre- 
cursor from the outer membrane into  the inner membrane 
requires A$, but not NTPs. We  followed the import of C'" 
313 to see if it involved the same specific steps. Reticulocyte 
lysate and mitochondria were either preincubated with a 
boiled apyrase preparation or received an active apyrase prep- 
aration (80 units/ml or 5 units/ml). Reticulocyte lysate and 
mitochondria were combined and incubated in the absence of 
A+ at 25  "C. After reisolation, the mitochondria were resus- 
pended in BSA-containing buffer in the presence of antimycin 
A, oligomycin, and apyrase. The reaction mixtures were 
halved, and one half was treated with trypsin to degrade the 
stage 2 intermediate. NTPs were  added and  a A$ was gener- 
ated by addition of ascorbate plus TMPD. Following incuba- 
tion at 25 "C, reactions were again halved, and one half  was 
treated with proteinase K (250  pg/ml). Reaction 7 of Fig. 4 
shows C1"313 which  could  be imported from the bound state 
under control conditions. Reaction 10 shows the  amount of 
specifically bound precursor which was protected against 
treatment with trypsin. Pretreatment of reticulocyte lysate 
and mitochondria with apyrase reduced the amount of specif- 
ically  bound precursor (Fig.  4, Reactions 8 and 9)  and com- 
pletely inhibited the generation of the trypsin-protected stage 
3 intermediate (Fig. 4, Reactions 11 and 12). 
Transport of C'"313 from the outer membrane (stage 3 
intermediate) to  the inner membrane required A$, but not 
NTPs; similar to the import of authentic ADP/ATP carrier 
(12), transport from the outer to  the inner membrane was 
stimulated by removal of NTPs  (not shown). 
In summary, specific binding of C1"313 to the mitochondrial 
surface and insertion into the outer membrane require NTPs. 
Translocation of  C104-313 from the  outer  into  the  inner mem- 
brane does not need NTPs.  Thus, C104-313 seems to follow the 
same specific steps as does the  authentic ADP/ATP carrier. 
Specific Binding and  Import of C'04-313  Require a Protease- 
sensitive Component on the Mitochondrial Surface-Mito- 
chondria were pretreated with trypsin at  concentrations 
which  do not degrade the outer membrane barrier (8,11,20). 
The mitochondria were then incubated with reticulocyte lys- 
ate containing C1"313 at  25 "C in the absence (Fig. 5A) or 
presence (Fig. 5B) of A$. Controls received mitochondria 
which had not been preincubated with trypsin (Fig. 5A, Re- 
action 1; Fig. 5B, Reaction 1) or which had been preincubated 
with trypsin plus trypsin inhibitor (Fig. 5B, Reaction 2). 
Reactions A were treated with proteinase K at  a concentration 
of 10 pg/ml  which preserved the stage 3 intermediate. Reac- 
tions B were treated with proteinase K at a concentration of 
250 pg/ml to test for imported C104-313. Pretreatment with 
trypsin inhibited the specific binding of  C1"313 (Fig. 5A, 
Reactions 2  and 3) and  the import of C1"-313 (Fig. 5B, Reac- 
tions 3 and 4). The precursor proteins in reticulocyte lysate 
were not degraded by incubation with trypsin-pretreated mi- 
tochondria (not shown). A protease-sensitive component on 
the mitochondrial surface, possibly a receptor site, is required 
at  an early stage of import of C104-313 into mitochondria. 
DISCUSSION 
We have  shown that the carboxyl-terminal two-thirds 
(amino acid residues 104-313)  of the ADP/ATP carrier poly- 
peptide is imported into mitochondria. There are several 
interesting reports that artificial (21), nonmitochondrial(22), 
or cryptic (23) signals or signals contained in a mitochondrial 
gene product (24) are able to direct proteins into mitochondria 
with low efficiency. Such import could  for  example  occur as a 
result of bypassing specific components of the import machin- 
ery (e.g. receptor sites). To ascertain if the carboxyl-terminal 
two-thirds of the ADP/ATP carrier contains specific mito- 
chondrial targeting information, we investigated the specific 
steps of the import pathway which are known  for the  authen- 
tic ADP/ATP carrier (7-9,11,12,25).  Import of the truncated 
precursor was mediated by a protease-sensitive component on 
the mitochondrial surface. Its binding to  the outer membrane 
occurred in two sequential steps; both of them required NTPs. 
The translocation from the  outer membrane into  the  inner 
membrane required A+, but not NTPs. The efficiency of 
import via the bound state  (ie.  the ratio between import of 
precursor via the bound state  and import of free precursor) 
was  close to 1 for the  truncatedprecursor  and for the  authentic 
ADP/ATP carrier. For all  other mitochondrial precursor pro- 
teins studied so far, the import efficiency  via the bound state 
was significantly lower (2, 9). This strongly suggests that  the 
truncated precursor contains mitochondrial targeting infor- 
mation specific  for the ADP/ATP carrier. 
Adrian et al. (6) reported that the amino-terminal 115 
amino acid  residues of the ADP/ATP carrier contained suf- 
ficient information for the targeting to mitochondria. So far, 
we cannot exclude the possibility that  the ADP/ATP carrier 
contains  its targeting signal(s) in the region  between amino 
acid  residues 104 and 115.  However,  by studying the published 
sequence of the ADP/ATP carrier (6, 13, 26), we proposed 
that  it contained multiple internal signal sequences (2); it is 
composed of three homologous domains of about 100 amino 
acid  residues each (13,27).  The carboxyl-terminal half of each 
domain contains a positively charged stretch of about 20 
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structure (28). Thus,  these  stretches  share  characteristics  with 
mitochondrial presequences (29). Dividing the  ADP/ATP  car- 
rier into three nonoverlapping parts corresponding to the 
three  domains allows testing of the  hypothesis  that  the  ADP/ 
ATP  carrier  contains multiple internal  targeting sequences. 
The overall efficiency of import (i.e. the ratio between 
imported  precursor  and  total  added  precursor) of C104-313 is  up 
to  30% of the  import efficiency of authentic  ADP/ATP  car- 
rier. This decreased import efficiency may be caused by lack 
of putative signals present  in  the  amino-terminal  third of the 
ADP/ATP  carrier  or by an  altered  conformation of C104-313. 
Further  studies  have  to  address  the  questions of which and 
how many of the proposed targeting signals are necessary  for 
correct  and efficient import of the  authentic  ADP/ATP  car- 
rier. 
Our  studies show for the  first  time  that  an  amino-terminal 
sequence of more than 100 residues is dispensable for specific 
import of a mitochondrial  precursor  protein. The general view 
that specific mitochondrial targeting information is largely 
confined to  the  (extreme)  amino-terminal region of a mito- 
chondrial precursor protein will have to be reconsidered. 
These findings  for the  ADP/ATP  carrier  are  corroborated by 
studies  with a structural  mutant of apocytochrome c which 
show that  alteration of the  carboxyl-terminal  precursor  part 
inhibits  import of apocytochrome c (16). Fusion  products of 
mitochondrial presequences and passenger proteins  are  often 
imported with very low efficiency. Taking  this  into  account 
we should consider the possibility that  mature  parts of cleav- 
able  mitochondrial  precursors  contain  important specific tar- 
geting information (besides the obvious role of mature  parts 
for an  import-competent  conformation (12, 30, 31)). Prelimi- 
nary results already suggest that the mature part of Fo- 
ATPase  subunit 9 is  (directly  or  indirectly) involved in  the 
A$-independent specific binding of the  subunit 9 precursor  to 
the mitochondrial surface.' Thus, the importance of non- 
amino-terminal precursor regions for specific import into 
mitochondria may not only be  restricted  to  precursors  without 
cleavable  presequences  (like the  ADP/ATP  carrier  and  apo- 
cytochrome c). 
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